# Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-outcomes-in-type-2-diabetes-mellitus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kenneth W. Mahaffey,Meg Jardine,Séverine Bompoint,Christopher P. Cannon,Bruce Neal,Hiddo J.L. Heerspink,David M. Charytan,Robert Edwards,Rajiv Agarwal,George L. Bakris,Scott Bull,George Capuano,Dick de Zeeuw,Tom Greene,Adeera Levin,Carol A. Pollock,Tao Sun,David C. Wheeler,Yshai Yavin,Hong Zhang,Bernard Zinman,Norman Rosenthal,Barry M. Brenner,Vlado Perkovic,On behalf of the CREDENCE Study Investigators |
| Citations | 291 |
| DOI | 10.1161/circulationaha.119.042007 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1161/circulationaha.119.042007 |
| OpenAlex ID | https://openalex.org/W2956532717 |
| PMID | 31291786 |
| Type | article |
| Year | 2019 |

## Paper authors

Showing 10 of 13.

- [Kenneth W. Mahaffey](https://scholariq.org/researchers/kenneth-w-mahaffey/)
- [Christopher P. Cannon](https://scholariq.org/researchers/christopher-p-cannon/)
- [Vlado Perkovic](https://scholariq.org/researchers/vlado-perkovic/)
- [Hiddo J.L. Heerspink](https://scholariq.org/researchers/hiddo-j-l-heerspink/)
- [Dick de Zeeuw](https://scholariq.org/researchers/dick-de-zeeuw/)
- [Adeera Levin](https://scholariq.org/researchers/adeera-levin/)
- [David C. Wheeler](https://scholariq.org/researchers/david-c-wheeler/)
- [Bruce Neal](https://scholariq.org/researchers/bruce-neal/)
- [Rajiv Agarwal](https://scholariq.org/researchers/rajiv-agarwal/)
- [Bernard Zinman](https://scholariq.org/researchers/bernard-zinman/)

## Paper funders

Showing 8 of 32.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Gilead Sciences](https://scholariq.org/funders/gilead-sciences/)

## Paper journal

- [Circulation](https://scholariq.org/journals/circulation/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.